Cue Biopharma: Driehaus reports 4.02% ownership stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cue Biopharma, Inc. (CUE) is the issuer in an amended ownership report from Driehaus Capital Management LLC. Driehaus reported beneficial ownership of 292,144 common shares, or 4.02%, as of September 30, 2026, and stated it had ceased being a beneficial owner of more than 5% of the class. It reported shared voting and shared dispositive power over all 292,144 shares, with no sole voting or dispositive power.
Key Figures
Key Terms
beneficially owned regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.